| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner
1 company
Forbion Growth Opportunities Fund I Cooperatief U.A. last filed a Form 4 in October 2024, as 10% Owner at ENGN.
Historically, Forbion Growth Opportunities Fund I Cooperatief U.A.'s trades have earned a strong insider score of 70/100 across 12 rated trades. Over a 12-month horizon, 66.7% of those trades were profitable, with an average 12-month return of +0.9%.
At the last filing, the largest reported position was 3,032,430 shares of ENGN. Net of sales, the ENGN filings show accumulation of 1,032,430 shares.
Forbion Growth Opportunities Fund I Cooperatief U.A. has 2 Form 4 filings on record from December 2023 to October 2024, all as 10% Owner at enGene (ENGN), 2023–2024.
The 14 reported transactions were 14 open-market purchases.
Counted by filing, the open-market trades come to 2 purchases worth about $8.0M and no sales.
The largest open-market purchase was 561,797 shares of ENGN at an average $8.90 on October 30, 2024, about $5.0M. Twelve months later ENGN was down 20%.
Shares as reported in the last Form 4 for each company; the most recent is from October 2024. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.